Glossary

Plain-English definitions of the terms used on this site.

These are general educational definitions. They do not replace an explanation from your own clinical team.

A

Adjuvant treatment
Treatment given after the main treatment (usually surgery) to reduce the risk of the cancer returning, such as chemotherapy, endocrine therapy, HER2-directed treatment or radiotherapy.
Autologous reconstruction
Breast reconstruction that uses the patient's own tissue, most commonly from the lower abdomen, transferred to the chest.
Axillary lymph-node dissection
An operation that removes a larger group of lymph nodes from under the arm. It may be required in some circumstances, depending on the findings.

B

Biomarker
A measurable feature of the cancer, such as ER, PR or HER2 status, that helps determine which treatments may be effective.
Breast-conserving surgery (BCS)
Removal of the tumor and a surrounding margin while preserving the rest of the breast. Also called lumpectomy, wide local excision or partial mastectomy. It is usually followed by radiotherapy.

C

Capsular contracture
Tightening of the scar tissue that naturally forms around a breast implant, which can cause firmness, distortion or discomfort.

D

DICOM
The standard digital format for medical imaging. Original DICOM files allow a specialist to review the full images, unlike a screenshot or a photograph of a printed film.
DIEP flap
A deep inferior epigastric perforator flap: autologous reconstruction that uses skin and fat from the lower abdomen while attempting to preserve the abdominal muscle.
Direct-to-implant reconstruction
Placement of a permanent implant during the mastectomy operation, in appropriately selected patients, without a separate expansion stage.
Ductal carcinoma in situ (DCIS)
Abnormal cells confined to the milk ducts that have not spread into the surrounding breast tissue. It is non-invasive and is staged and treated differently from invasive cancer.

E

Estrogen receptor (ER)
A biomarker indicating whether the cancer may respond to endocrine (hormonal) therapy.

H

HER2
Human epidermal growth factor receptor 2, a biomarker that helps determine whether HER2-directed treatment may be effective.

I

Invasive breast cancer
Cancer that has grown beyond the ducts or lobules into the surrounding breast tissue, in contrast to carcinoma in situ.

K

Ki-67
A marker of how quickly cancer cells are dividing, sometimes reported to help describe the tumor.

L

Lymphedema
Swelling, usually of the arm, that can follow lymph-node surgery or radiotherapy. The risk is higher after more extensive lymph-node surgery.
Lymphovascular invasion
The presence of cancer cells within small blood or lymph vessels, sometimes noted in a pathology report.

M

Mastectomy
Removal of most or all of the breast tissue. The amount of skin removed and whether the nipple is preserved vary according to the cancer and the reconstructive plan.
Microsurgery
Surgery performed under a microscope to reconnect small blood vessels, used in autologous reconstruction such as a DIEP flap.

N

Neoadjuvant treatment
Systemic treatment, such as chemotherapy, given before surgery.
Nipple-sparing mastectomy (NSM)
A mastectomy that preserves the breast skin and the nipple–areola complex. It is available only for appropriately selected patients, and preserving the nipple does not preserve normal sensation.

O

Oncoplastic surgery
Breast-conserving surgery combined with techniques to reshape the remaining breast tissue.

P

Post-mastectomy radiotherapy (PMRT)
Radiotherapy given after mastectomy to reduce the risk of cancer returning in the chest wall or regional lymph nodes. It is based on cancer-related factors and can affect reconstruction.
Progesterone receptor (PR)
A biomarker reported alongside ER that relates to the likely benefit of endocrine therapy.

S

Sentinel lymph-node biopsy
Removal of a limited number of selected lymph nodes — the first to drain the breast — to check whether cancer has spread.
Skin-sparing mastectomy
A mastectomy that preserves much of the breast skin to support reconstruction.

T

Tissue expander
A temporary adjustable device placed after mastectomy and gradually filled to create space for a later permanent implant.
Tumor grade
A description of how abnormal the cancer cells look under the microscope, included in a pathology report.